Passive Transdermal Drug Delivery Market - Global Outlook and Forecast 2021-2027

Passive Transdermal Drug Delivery Market - Global Outlook and Forecast 2021-2027

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Passive Transdermal Drug Delivery Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Passive Transdermal Drug Delivery Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Passive Transdermal Drug Delivery Overall Market Size
2.1 Global Passive Transdermal Drug Delivery Market Size: 2021 VS 2027
2.2 Global Passive Transdermal Drug Delivery Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Passive Transdermal Drug Delivery Sales (Consumption): 2016-2027
3 Company Landscape
3.1 Top Passive Transdermal Drug Delivery Players in Global Market
3.2 Top Global Passive Transdermal Drug Delivery Companies Ranked by Revenue
3.3 Global Passive Transdermal Drug Delivery Revenue by Companies
3.4 Global Passive Transdermal Drug Delivery Sales by Companies
3.5 Global Passive Transdermal Drug Delivery Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Passive Transdermal Drug Delivery Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Passive Transdermal Drug Delivery Product Type
3.8 Tier 1, Tier 2 and Tier 3 Passive Transdermal Drug Delivery Players in Global Market
3.8.1 List of Global Tier 1 Passive Transdermal Drug Delivery Companies
3.8.2 List of Global Tier 2 and Tier 3 Passive Transdermal Drug Delivery Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Passive Transdermal Drug Delivery Market Size Markets, 2021 & 2027
4.1.2 Microfluidics
4.1.3 Smart Pill Technology (SPT)
4.2 By Type - Global Passive Transdermal Drug Delivery Revenue & Forecasts
4.2.1 By Type - Global Passive Transdermal Drug Delivery Revenue, 2016-2021
4.2.2 By Type - Global Passive Transdermal Drug Delivery Revenue, 2022-2027
4.2.3 By Type - Global Passive Transdermal Drug Delivery Revenue Market Share, 2016-2027
4.3 By Type - Global Passive Transdermal Drug Delivery Sales & Forecasts
4.3.1 By Type - Global Passive Transdermal Drug Delivery Sales, 2016-2021
4.3.2 By Type - Global Passive Transdermal Drug Delivery Sales, 2022-2027
4.3.3 By Type - Global Passive Transdermal Drug Delivery Sales Market Share, 2016-2027
4.4 By Type - Global Passive Transdermal Drug Delivery Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Passive Transdermal Drug Delivery Market Size, 2021 & 2027
5.1.2 Clinic
5.1.3 Hospital
5.1.4 Others
5.2 By Application - Global Passive Transdermal Drug Delivery Revenue & Forecasts
5.2.1 By Application - Global Passive Transdermal Drug Delivery Revenue, 2016-2021
5.2.2 By Application - Global Passive Transdermal Drug Delivery Revenue, 2022-2027
5.2.3 By Application - Global Passive Transdermal Drug Delivery Revenue Market Share, 2016-2027
5.3 By Application - Global Passive Transdermal Drug Delivery Sales & Forecasts
5.3.1 By Application - Global Passive Transdermal Drug Delivery Sales, 2016-2021
5.3.2 By Application - Global Passive Transdermal Drug Delivery Sales, 2022-2027
5.3.3 By Application - Global Passive Transdermal Drug Delivery Sales Market Share, 2016-2027
5.4 By Application - Global Passive Transdermal Drug Delivery Price (Manufacturers Selling Prices), 2016-2027
6 Sights by Region
6.1 By Region - Global Passive Transdermal Drug Delivery Market Size, 2021 & 2027
6.2 By Region - Global Passive Transdermal Drug Delivery Revenue & Forecasts
6.2.1 By Region - Global Passive Transdermal Drug Delivery Revenue, 2016-2021
6.2.2 By Region - Global Passive Transdermal Drug Delivery Revenue, 2022-2027
6.2.3 By Region - Global Passive Transdermal Drug Delivery Revenue Market Share, 2016-2027
6.3 By Region - Global Passive Transdermal Drug Delivery Sales & Forecasts
6.3.1 By Region - Global Passive Transdermal Drug Delivery Sales, 2016-2021
6.3.2 By Region - Global Passive Transdermal Drug Delivery Sales, 2022-2027
6.3.3 By Region - Global Passive Transdermal Drug Delivery Sales Market Share, 2016-2027
6.4 North America
6.4.1 By Country - North America Passive Transdermal Drug Delivery Revenue, 2016-2027
6.4.2 By Country - North America Passive Transdermal Drug Delivery Sales, 2016-2027
6.4.3 US Passive Transdermal Drug Delivery Market Size, 2016-2027
6.4.4 Canada Passive Transdermal Drug Delivery Market Size, 2016-2027
6.4.5 Mexico Passive Transdermal Drug Delivery Market Size, 2016-2027
6.5 Europe
6.5.1 By Country - Europe Passive Transdermal Drug Delivery Revenue, 2016-2027
6.5.2 By Country - Europe Passive Transdermal Drug Delivery Sales, 2016-2027
6.5.3 Germany Passive Transdermal Drug Delivery Market Size, 2016-2027
6.5.4 France Passive Transdermal Drug Delivery Market Size, 2016-2027
6.5.5 U.K. Passive Transdermal Drug Delivery Market Size, 2016-2027
6.5.6 Italy Passive Transdermal Drug Delivery Market Size, 2016-2027
6.5.7 Russia Passive Transdermal Drug Delivery Market Size, 2016-2027
6.5.8 Nordic Countries Passive Transdermal Drug Delivery Market Size, 2016-2027
6.5.9 Benelux Passive Transdermal Drug Delivery Market Size, 2016-2027
6.6 Asia
6.6.1 By Region - Asia Passive Transdermal Drug Delivery Revenue, 2016-2027
6.6.2 By Region - Asia Passive Transdermal Drug Delivery Sales, 2016-2027
6.6.3 China Passive Transdermal Drug Delivery Market Size, 2016-2027
6.6.4 Japan Passive Transdermal Drug Delivery Market Size, 2016-2027
6.6.5 South Korea Passive Transdermal Drug Delivery Market Size, 2016-2027
6.6.6 Southeast Asia Passive Transdermal Drug Delivery Market Size, 2016-2027
6.6.7 India Passive Transdermal Drug Delivery Market Size, 2016-2027
6.7 South America
6.7.1 By Country - South America Passive Transdermal Drug Delivery Revenue, 2016-2027
6.7.2 By Country - South America Passive Transdermal Drug Delivery Sales, 2016-2027
6.7.3 Brazil Passive Transdermal Drug Delivery Market Size, 2016-2027
6.7.4 Argentina Passive Transdermal Drug Delivery Market Size, 2016-2027
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Passive Transdermal Drug Delivery Revenue, 2016-2027
6.8.2 By Country - Middle East & Africa Passive Transdermal Drug Delivery Sales, 2016-2027
6.8.3 Turkey Passive Transdermal Drug Delivery Market Size, 2016-2027
6.8.4 Israel Passive Transdermal Drug Delivery Market Size, 2016-2027
6.8.5 Saudi Arabia Passive Transdermal Drug Delivery Market Size, 2016-2027
6.8.6 UAE Passive Transdermal Drug Delivery Market Size, 2016-2027
7 Manufacturers & Brands Profiles
7.1 3M
7.1.1 3M Corporate Summary
7.1.2 3M Business Overview
7.1.3 3M Passive Transdermal Drug Delivery Major Product Offerings
7.1.4 3M Passive Transdermal Drug Delivery Sales and Revenue in Global (2016-2021)
7.1.5 3M Key News
7.2 Actavis, Inc.
7.2.1 Actavis, Inc. Corporate Summary
7.2.2 Actavis, Inc. Business Overview
7.2.3 Actavis, Inc. Passive Transdermal Drug Delivery Major Product Offerings
7.2.4 Actavis, Inc. Passive Transdermal Drug Delivery Sales and Revenue in Global (2016-2021)
7.2.5 Actavis, Inc. Key News
7.3 Bayer AG
7.3.1 Bayer AG Corporate Summary
7.3.2 Bayer AG Business Overview
7.3.3 Bayer AG Passive Transdermal Drug Delivery Major Product Offerings
7.3.4 Bayer AG Passive Transdermal Drug Delivery Sales and Revenue in Global (2016-2021)
7.3.5 Bayer AG Key News
7.4 Boehringer Ingelheim GmbH
7.4.1 Boehringer Ingelheim GmbH Corporate Summary
7.4.2 Boehringer Ingelheim GmbH Business Overview
7.4.3 Boehringer Ingelheim GmbH Passive Transdermal Drug Delivery Major Product Offerings
7.4.4 Boehringer Ingelheim GmbH Passive Transdermal Drug Delivery Sales and Revenue in Global (2016-2021)
7.4.5 Boehringer Ingelheim GmbH Key News
7.5 Corium International, Inc.
7.5.1 Corium International, Inc. Corporate Summary
7.5.2 Corium International, Inc. Business Overview
7.5.3 Corium International, Inc. Passive Transdermal Drug Delivery Major Product Offerings
7.5.4 Corium International, Inc. Passive Transdermal Drug Delivery Sales and Revenue in Global (2016-2021)
7.5.5 Corium International, Inc. Key News
7.6 Echo Therapeutics, Inc.
7.6.1 Echo Therapeutics, Inc. Corporate Summary
7.6.2 Echo Therapeutics, Inc. Business Overview
7.6.3 Echo Therapeutics, Inc. Passive Transdermal Drug Delivery Major Product Offerings
7.6.4 Echo Therapeutics, Inc. Passive Transdermal Drug Delivery Sales and Revenue in Global (2016-2021)
7.6.5 Echo Therapeutics, Inc. Key News
7.7 GlaxoSmithKline plc
7.7.1 GlaxoSmithKline plc Corporate Summary
7.7.2 GlaxoSmithKline plc Business Overview
7.7.3 GlaxoSmithKline plc Passive Transdermal Drug Delivery Major Product Offerings
7.4.4 GlaxoSmithKline plc Passive Transdermal Drug Delivery Sales and Revenue in Global (2016-2021)
7.7.5 GlaxoSmithKline plc Key News
7.8 Johnson & Johnson (Janssen Pharmaceuticals Inc.)
7.8.1 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Corporate Summary
7.8.2 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Business Overview
7.8.3 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Passive Transdermal Drug Delivery Major Product Offerings
7.8.4 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Passive Transdermal Drug Delivery Sales and Revenue in Global (2016-2021)
7.8.5 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Key News
7.9 Mylan N.V.
7.9.1 Mylan N.V. Corporate Summary
7.9.2 Mylan N.V. Business Overview
7.9.3 Mylan N.V. Passive Transdermal Drug Delivery Major Product Offerings
7.9.4 Mylan N.V. Passive Transdermal Drug Delivery Sales and Revenue in Global (2016-2021)
7.9.5 Mylan N.V. Key News
7.10 Novartis AG
7.10.1 Novartis AG Corporate Summary
7.10.2 Novartis AG Business Overview
7.10.3 Novartis AG Passive Transdermal Drug Delivery Major Product Offerings
7.10.4 Novartis AG Passive Transdermal Drug Delivery Sales and Revenue in Global (2016-2021)
7.10.5 Novartis AG Key News
7.11 Noven Pharmaceuticals, Inc.
7.11.1 Noven Pharmaceuticals, Inc. Corporate Summary
7.11.2 Noven Pharmaceuticals, Inc. Passive Transdermal Drug Delivery Business Overview
7.11.3 Noven Pharmaceuticals, Inc. Passive Transdermal Drug Delivery Major Product Offerings
7.11.4 Noven Pharmaceuticals, Inc. Passive Transdermal Drug Delivery Sales and Revenue in Global (2016-2021)
7.11.5 Noven Pharmaceuticals, Inc. Key News
7.12 Transdermal Corp.
7.12.1 Transdermal Corp. Corporate Summary
7.12.2 Transdermal Corp. Passive Transdermal Drug Delivery Business Overview
7.12.3 Transdermal Corp. Passive Transdermal Drug Delivery Major Product Offerings
7.12.4 Transdermal Corp. Passive Transdermal Drug Delivery Sales and Revenue in Global (2016-2021)
7.12.5 Transdermal Corp. Key News
8 Global Passive Transdermal Drug Delivery Production Capacity, Analysis
8.1 Global Passive Transdermal Drug Delivery Production Capacity, 2016-2027
8.2 Passive Transdermal Drug Delivery Production Capacity of Key Manufacturers in Global Market
8.3 Global Passive Transdermal Drug Delivery Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Passive Transdermal Drug Delivery Supply Chain Analysis
10.1 Passive Transdermal Drug Delivery Industry Value Chain
10.2 Passive Transdermal Drug Delivery Upstream Market
10.3 Passive Transdermal Drug Delivery Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Passive Transdermal Drug Delivery Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Passive Transdermal Drug Delivery in Global Market
Table 2. Top Passive Transdermal Drug Delivery Players in Global Market, Ranking by Revenue (2019)
Table 3. Global Passive Transdermal Drug Delivery Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global Passive Transdermal Drug Delivery Revenue Share by Companies, 2016-2021
Table 5. Global Passive Transdermal Drug Delivery Sales by Companies, (K Units), 2016-2021
Table 6. Global Passive Transdermal Drug Delivery Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Passive Transdermal Drug Delivery Price (2016-2021) & (USD/Unit)
Table 8. Global Manufacturers Passive Transdermal Drug Delivery Product Type
Table 9. List of Global Tier 1 Passive Transdermal Drug Delivery Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Passive Transdermal Drug Delivery Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - Global Passive Transdermal Drug Delivery Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Global Passive Transdermal Drug Delivery Revenue (US$, Mn), 2016-2021
Table 13. By Type - Global Passive Transdermal Drug Delivery Revenue (US$, Mn), 2022-2027
Table 14. By Type - Global Passive Transdermal Drug Delivery Sales (K Units), 2016-2021
Table 15. By Type - Global Passive Transdermal Drug Delivery Sales (K Units), 2022-2027
Table 16. By Application - Global Passive Transdermal Drug Delivery Revenue, (US$, Mn), 2021 VS 2027
Table 17. By Application - Global Passive Transdermal Drug Delivery Revenue (US$, Mn), 2016-2021
Table 18. By Application - Global Passive Transdermal Drug Delivery Revenue (US$, Mn), 2022-2027
Table 19. By Application - Global Passive Transdermal Drug Delivery Sales (K Units), 2016-2021
Table 20. By Application - Global Passive Transdermal Drug Delivery Sales (K Units), 2022-2027
Table 21. By Region - Global Passive Transdermal Drug Delivery Revenue, (US$, Mn), 2021 VS 2027
Table 22. By Region - Global Passive Transdermal Drug Delivery Revenue (US$, Mn), 2016-2021
Table 23. By Region - Global Passive Transdermal Drug Delivery Revenue (US$, Mn), 2022-2027
Table 24. By Region - Global Passive Transdermal Drug Delivery Sales (K Units), 2016-2021
Table 25. By Region - Global Passive Transdermal Drug Delivery Sales (K Units), 2022-2027
Table 26. By Country - North America Passive Transdermal Drug Delivery Revenue, (US$, Mn), 2016-2021
Table 27. By Country - North America Passive Transdermal Drug Delivery Revenue, (US$, Mn), 2022-2027
Table 28. By Country - North America Passive Transdermal Drug Delivery Sales, (K Units), 2016-2021
Table 29. By Country - North America Passive Transdermal Drug Delivery Sales, (K Units), 2022-2027
Table 30. By Country - Europe Passive Transdermal Drug Delivery Revenue, (US$, Mn), 2016-2021
Table 31. By Country - Europe Passive Transdermal Drug Delivery Revenue, (US$, Mn), 2022-2027
Table 32. By Country - Europe Passive Transdermal Drug Delivery Sales, (K Units), 2016-2021
Table 33. By Country - Europe Passive Transdermal Drug Delivery Sales, (K Units), 2022-2027
Table 34. By Region - Asia Passive Transdermal Drug Delivery Revenue, (US$, Mn), 2016-2021
Table 35. By Region - Asia Passive Transdermal Drug Delivery Revenue, (US$, Mn), 2022-2027
Table 36. By Region - Asia Passive Transdermal Drug Delivery Sales, (K Units), 2016-2021
Table 37. By Region - Asia Passive Transdermal Drug Delivery Sales, (K Units), 2022-2027
Table 38. By Country - South America Passive Transdermal Drug Delivery Revenue, (US$, Mn), 2016-2021
Table 39. By Country - South America Passive Transdermal Drug Delivery Revenue, (US$, Mn), 2022-2027
Table 40. By Country - South America Passive Transdermal Drug Delivery Sales, (K Units), 2016-2021
Table 41. By Country - South America Passive Transdermal Drug Delivery Sales, (K Units), 2022-2027
Table 42. By Country - Middle East & Africa Passive Transdermal Drug Delivery Revenue, (US$, Mn), 2016-2021
Table 43. By Country - Middle East & Africa Passive Transdermal Drug Delivery Revenue, (US$, Mn), 2022-2027
Table 44. By Country - Middle East & Africa Passive Transdermal Drug Delivery Sales, (K Units), 2016-2021
Table 45. By Country - Middle East & Africa Passive Transdermal Drug Delivery Sales, (K Units), 2022-2027
Table 46. 3M Corporate Summary
Table 47. 3M Passive Transdermal Drug Delivery Product Offerings
Table 48. 3M Passive Transdermal Drug Delivery Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 49. Actavis, Inc. Corporate Summary
Table 50. Actavis, Inc. Passive Transdermal Drug Delivery Product Offerings
Table 51. Actavis, Inc. Passive Transdermal Drug Delivery Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 52. Bayer AG Corporate Summary
Table 53. Bayer AG Passive Transdermal Drug Delivery Product Offerings
Table 54. Bayer AG Passive Transdermal Drug Delivery Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 55. Boehringer Ingelheim GmbH Corporate Summary
Table 56. Boehringer Ingelheim GmbH Passive Transdermal Drug Delivery Product Offerings
Table 57. Boehringer Ingelheim GmbH Passive Transdermal Drug Delivery Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 58. Corium International, Inc. Corporate Summary
Table 59. Corium International, Inc. Passive Transdermal Drug Delivery Product Offerings
Table 60. Corium International, Inc. Passive Transdermal Drug Delivery Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 61. Echo Therapeutics, Inc. Corporate Summary
Table 62. Echo Therapeutics, Inc. Passive Transdermal Drug Delivery Product Offerings
Table 63. Echo Therapeutics, Inc. Passive Transdermal Drug Delivery Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 64. GlaxoSmithKline plc Corporate Summary
Table 65. GlaxoSmithKline plc Passive Transdermal Drug Delivery Product Offerings
Table 66. GlaxoSmithKline plc Passive Transdermal Drug Delivery Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 67. Johnson & Johnson (Janssen Pharmaceuticals Inc.) Corporate Summary
Table 68. Johnson & Johnson (Janssen Pharmaceuticals Inc.) Passive Transdermal Drug Delivery Product Offerings
Table 69. Johnson & Johnson (Janssen Pharmaceuticals Inc.) Passive Transdermal Drug Delivery Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 70. Mylan N.V. Corporate Summary
Table 71. Mylan N.V. Passive Transdermal Drug Delivery Product Offerings
Table 72. Mylan N.V. Passive Transdermal Drug Delivery Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 73. Novartis AG Corporate Summary
Table 74. Novartis AG Passive Transdermal Drug Delivery Product Offerings
Table 75. Novartis AG Passive Transdermal Drug Delivery Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 76. Noven Pharmaceuticals, Inc. Corporate Summary
Table 77. Noven Pharmaceuticals, Inc. Passive Transdermal Drug Delivery Product Offerings
Table 78. Noven Pharmaceuticals, Inc. Passive Transdermal Drug Delivery Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 79. Transdermal Corp. Corporate Summary
Table 80. Transdermal Corp. Passive Transdermal Drug Delivery Product Offerings
Table 81. Transdermal Corp. Passive Transdermal Drug Delivery Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 82. Passive Transdermal Drug Delivery Production Capacity (K Units) of Key Manufacturers in Global Market, 2019-2021 (K Units)
Table 83. Global Passive Transdermal Drug Delivery Capacity Market Share of Key Manufacturers, 2019-2021
Table 84. Global Passive Transdermal Drug Delivery Production by Region, 2016-2021 (K Units)
Table 85. Global Passive Transdermal Drug Delivery Production by Region, 2022-2027 (K Units)
Table 86. Passive Transdermal Drug Delivery Market Opportunities & Trends in Global Market
Table 87. Passive Transdermal Drug Delivery Market Drivers in Global Market
Table 88. Passive Transdermal Drug Delivery Market Restraints in Global Market
Table 89. Passive Transdermal Drug Delivery Raw Materials
Table 90. Passive Transdermal Drug Delivery Raw Materials Suppliers in Global Market
Table 91. Typical Passive Transdermal Drug Delivery Downstream
Table 92. Passive Transdermal Drug Delivery Downstream Clients in Global Market
Table 93. Passive Transdermal Drug Delivery Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Passive Transdermal Drug Delivery Segment by Type
Figure 2. Passive Transdermal Drug Delivery Segment by Application
Figure 3. Global Passive Transdermal Drug Delivery Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Passive Transdermal Drug Delivery Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Passive Transdermal Drug Delivery Revenue, 2016-2027 (US$, Mn)
Figure 7. Passive Transdermal Drug Delivery Sales in Global Market: 2016-2027 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Passive Transdermal Drug Delivery Revenue in 2020
Figure 9. By Type - Global Passive Transdermal Drug Delivery Sales Market Share, 2016-2027
Figure 10. By Type - Global Passive Transdermal Drug Delivery Revenue Market Share, 2016-2027
Figure 11. By Type - Global Passive Transdermal Drug Delivery Price (USD/Unit), 2016-2027
Figure 12. By Application - Global Passive Transdermal Drug Delivery Sales Market Share, 2016-2027
Figure 13. By Application - Global Passive Transdermal Drug Delivery Revenue Market Share, 2016-2027
Figure 14. By Application - Global Passive Transdermal Drug Delivery Price (USD/Unit), 2016-2027
Figure 15. By Region - Global Passive Transdermal Drug Delivery Sales Market Share, 2016-2027
Figure 16. By Region - Global Passive Transdermal Drug Delivery Revenue Market Share, 2016-2027
Figure 17. By Country - North America Passive Transdermal Drug Delivery Revenue Market Share, 2016-2027
Figure 18. By Country - North America Passive Transdermal Drug Delivery Sales Market Share, 2016-2027
Figure 19. US Passive Transdermal Drug Delivery Revenue, (US$, Mn), 2016-2027
Figure 20. Canada Passive Transdermal Drug Delivery Revenue, (US$, Mn), 2016-2027
Figure 21. Mexico Passive Transdermal Drug Delivery Revenue, (US$, Mn), 2016-2027
Figure 22. By Country - Europe Passive Transdermal Drug Delivery Revenue Market Share, 2016-2027
Figure 23. By Country - Europe Passive Transdermal Drug Delivery Sales Market Share, 2016-2027
Figure 24. Germany Passive Transdermal Drug Delivery Revenue, (US$, Mn), 2016-2027
Figure 25. France Passive Transdermal Drug Delivery Revenue, (US$, Mn), 2016-2027
Figure 26. U.K. Passive Transdermal Drug Delivery Revenue, (US$, Mn), 2016-2027
Figure 27. Italy Passive Transdermal Drug Delivery Revenue, (US$, Mn), 2016-2027
Figure 28. Russia Passive Transdermal Drug Delivery Revenue, (US$, Mn), 2016-2027
Figure 29. Nordic Countries Passive Transdermal Drug Delivery Revenue, (US$, Mn), 2016-2027
Figure 30. Benelux Passive Transdermal Drug Delivery Revenue, (US$, Mn), 2016-2027
Figure 31. By Region - Asia Passive Transdermal Drug Delivery Revenue Market Share, 2016-2027
Figure 32. By Region - Asia Passive Transdermal Drug Delivery Sales Market Share, 2016-2027
Figure 33. China Passive Transdermal Drug Delivery Revenue, (US$, Mn), 2016-2027
Figure 34. Japan Passive Transdermal Drug Delivery Revenue, (US$, Mn), 2016-2027
Figure 35. South Korea Passive Transdermal Drug Delivery Revenue, (US$, Mn), 2016-2027
Figure 36. Southeast Asia Passive Transdermal Drug Delivery Revenue, (US$, Mn), 2016-2027
Figure 37. India Passive Transdermal Drug Delivery Revenue, (US$, Mn), 2016-2027
Figure 38. By Country - South America Passive Transdermal Drug Delivery Revenue Market Share, 2016-2027
Figure 39. By Country - South America Passive Transdermal Drug Delivery Sales Market Share, 2016-2027
Figure 40. Brazil Passive Transdermal Drug Delivery Revenue, (US$, Mn), 2016-2027
Figure 41. Argentina Passive Transdermal Drug Delivery Revenue, (US$, Mn), 2016-2027
Figure 42. By Country - Middle East & Africa Passive Transdermal Drug Delivery Revenue Market Share, 2016-2027
Figure 43. By Country - Middle East & Africa Passive Transdermal Drug Delivery Sales Market Share, 2016-2027
Figure 44. Turkey Passive Transdermal Drug Delivery Revenue, (US$, Mn), 2016-2027
Figure 45. Israel Passive Transdermal Drug Delivery Revenue, (US$, Mn), 2016-2027
Figure 46. Saudi Arabia Passive Transdermal Drug Delivery Revenue, (US$, Mn), 2016-2027
Figure 47. UAE Passive Transdermal Drug Delivery Revenue, (US$, Mn), 2016-2027
Figure 48. Global Passive Transdermal Drug Delivery Production Capacity (K Units), 2016-2027
Figure 49. The Percentage of Production Passive Transdermal Drug Delivery by Region, 2020 VS 2027
Figure 50. Passive Transdermal Drug Delivery Industry Value Chain
Figure 51. Marketing Channels

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs